SciVision Biotech - Stock

SciVision Biotech P/E 2024

SciVision Biotech P/E

23.73

Ticker

1786.TW

ISIN

TW0001786002

As of Jul 1, 2024, SciVision Biotech's P/E ratio was 23.73, a -19.5% change from the 29.48 P/E ratio recorded in the previous year.

The SciVision Biotech P/E history

SciVision Biotech Aktienanalyse

What does SciVision Biotech do?

SciVision Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering SciVision Biotech's P/E Ratio

The Price to Earnings (P/E) Ratio of SciVision Biotech is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing SciVision Biotech's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of SciVision Biotech is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in SciVision Biotech’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about SciVision Biotech Stock

What is the price-to-earnings ratio of SciVision Biotech?

The price-earnings ratio of SciVision Biotech is currently 23.73.

How has the price-earnings ratio of SciVision Biotech changed compared to last year?

The price-to-earnings ratio of SciVision Biotech has increased by -19.5% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of SciVision Biotech high compared to other companies?

Yes, the price-to-earnings ratio of SciVision Biotech is high compared to other companies.

How does an increase in the price-earnings ratio of SciVision Biotech affect the company?

An increase in the price-earnings ratio of SciVision Biotech would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of SciVision Biotech affect the company?

A decrease in the price-earnings ratio of SciVision Biotech would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of SciVision Biotech?

Some factors that influence the price-earnings ratio of SciVision Biotech are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does SciVision Biotech pay?

Over the past 12 months, SciVision Biotech paid a dividend of 1.98 TWD . This corresponds to a dividend yield of about 1.49 %. For the coming 12 months, SciVision Biotech is expected to pay a dividend of 2.04 TWD.

What is the dividend yield of SciVision Biotech?

The current dividend yield of SciVision Biotech is 1.49 %.

When does SciVision Biotech pay dividends?

SciVision Biotech pays a quarterly dividend. This is distributed in the months of October, November, August, August.

How secure is the dividend of SciVision Biotech?

SciVision Biotech paid dividends every year for the past 8 years.

What is the dividend of SciVision Biotech?

For the upcoming 12 months, dividends amounting to 2.04 TWD are expected. This corresponds to a dividend yield of 1.53 %.

In which sector is SciVision Biotech located?

SciVision Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SciVision Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SciVision Biotech from 8/18/2023 amounting to 1.98 TWD, you needed to have the stock in your portfolio before the ex-date on 7/26/2023.

When did SciVision Biotech pay the last dividend?

The last dividend was paid out on 8/18/2023.

What was the dividend of SciVision Biotech in the year 2023?

In the year 2023, SciVision Biotech distributed 1.418 TWD as dividends.

In which currency does SciVision Biotech pay out the dividend?

The dividends of SciVision Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SciVision Biotech

Our stock analysis for SciVision Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciVision Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.